加拿大全国炎症性肠病发病率与患病率预测分析
基于加拿大8省健康行政数据的人群监测队列,分析2007-2014年IBD发病率及2002-2014年患病率,采用自回归积分滑动平均模型预测至2035年。预计2023年发病率为29.9/10万,2035年升至31.2/10万;患病率从2023年843/10万升至2035年1098/10万,儿童发病率上升而成人稳定。
要点
- 加拿大IBD发病率预计从2023年29.9/10万升至2035年31.2/10万,年均变化0.36%。
- 儿童(<18岁)IBD发病率年均增长1.27%,成人稳定(0.26%)。
- 患病率预计从2023年843/10万升至2035年1098/10万,老年人群最高。
核心结论
- 未来十年加拿大医疗系统将面临儿童IBD发病率上升和人口老龄化驱动总体患病率上升的双重挑战。
研究设计与样本
- 基于加拿大8省健康行政数据的人群监测队列,评估全国IBD发病率(2007-2014)和患病率(2002-2014)。
- 采用自回归积分滑动平均模型预测至2035年,按年龄分层并提供95%预测区间。
主要发现
- 2023年IBD发病率估计为29.9/10万(95% PI 28.3-31.5),预计2035年为31.2/10万(95% PI 28.1-34.3)。
- 儿童(<18岁)发病率年均变化1.27%(95% CI 0.82-1.67),成人年均变化0.26%(95% CI -0.42-0.82)。
- 2023年患病率为843/10万(95% PI 716-735),预计2035年升至1098/10万(95% PI 1068-1127)。
- 老年IBD患者患病率最高,2023年为1174/10万,年均变化2.78%(95% CI 2.75-2.81)。
临床怎么用
- 提示临床需关注儿童IBD发病上升趋势及老年IBD患者的管理需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Canada has a high burden of inflammatory bowel disease (IBD). Historical trends of IBD incidence and prevalence were analyzed to forecast the Canadian burden over the next decade. METHODS: Population-based surveillance cohorts in 8 provinces derived from health administrative data assessed the national incidence (2007-2014) and prevalence (2002-2014) of IBD. Autoregressive integrated moving average models were used to forecast incidence and prevalence, stratified by age, with 95% prediction intervals (PI), to 2035. The average annual percentage change (AAPC) with 95% confidence interval (CI) was calculated for the forecasted incidence and prevalence. RESULTS: The national incidence of IBD is estimated to be 29.9 per 100,000 (95% PI 28.3-31.5) in 2023. With a stable AAPC of 0.36% (95% CI -0.05 to 0.72), the incidence of IBD is forecasted to be 31.2 per 100,000 (95% PI 28.1-34.3) in 2035. The incidence in pediatric patients (younger than 18 years) is increasing (AAPC 1.27%; 95% CI 0.82-1.67), but it is stable in adults (AAPC 0.26%; 95% CI -0.42 to 0.82). The prevalence of IBD in Canada was 843 per 100,000 (95% PI 716-735) in 2023 and is expected to steadily climb (AAPC 2.43%; 95% CI 2.32-2.54) to 1,098 per 100,000 (95% PI 1,068-1,127) by 2035. The highest prevalence is in seniors with IBD (1,174 per 100,000 in 2023; AAPC 2.78%; 95% CI 2.75-2.81). DISCUSSION: Over the next decade, the Canadian health care systems will contend with the juxtaposition of rising incidence of pediatric IBD and a rising prevalence of overall IBD driven by the aging population.
引用
- Coward S, Benchimol EI, Bernstein CN, et al. Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis. Am J Gastroenterol. 2024. PMID: 38299598. doi:10.14309/ajg.0000000000002687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。